There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Serum PSA levels are used to predict the prognosis of patients with prostate cancer, but assessment of the prognostic accuracy of PSA values is difficult, particularly in populations in which ...

In summary, it seems that obese men with a low risk of developing prostate cancer have lower serum PSA levels than their non ... glands removed during RP does not seem to be uniform.

A MAN suffering from a common cancer was forced to have his entire penis amputated after it spread ... prostate specific antigen (PSA) test. The normal range is between 1.0 and 1.5 ng/ml, but high ...

Most prostate cancers are slow growing; however, there are cases of aggressive prostate cancers. The cancer cells may metastasize (spread ... The PSA test increases cancer detection but does ...

Cancer does not discriminate ... of developing prostate cancer and dying from the disease, Black men are more likely to have early cancer detection through screening. The main prostate cancer ...

PSA is a protein produced by normal cells in the prostate, but also by prostate cancer cells. It’s normal to have a small amount of PSA in your blood, and as you get older and your prostate gets ...

The NHS does not offer routine prostate-specific antigen (PSA) blood testing for prostate cancer, but says people may be offered the test if their doctor thinks they have symptoms of the disease.